一个开源的R套件用于检测临床试验中报告不足的不良事件:IMPALA (公司间质量分析) 联盟的实施和验证
Björn Koneswarakantha1, Ronojit Adyanthaya2, Jennifer Emerson3
1F. Hoffmann-La Roche AG, 4070, Basel, Switzerland.
Therapeutic innovation & regulatory science
|April 2, 2024
概括
一个开源的R包,simarep,有效地检测在临床试验中不充分报告的不良事件 (AE). 该工具通过提供快速,全面和近乎实时的现场级AE报告分析来提高数据完整性和患者安全.
科学领域:
- 临床试验方法论 临床试验方法论
- 药物监督 药物监督 药物监督
- 在医疗保健中的数据科学.
背景情况:
- 准确的不良事件 (AE) 报告对于临床试验完整性和患者安全至关重要.
- 对AE报告不足仍然是一个重大挑战,在良好的临床实践 (GCP) 审计中经常被发现.
- 目前的方法,如手动源数据验证 (SDV),在有效检测AE报告不足方面存在局限性.
研究的目的:
- 引入和验证开源R包,simarep,用于检测AE报告不足.
- 评估软件包在现场层面快速,全面,近乎实时地检测AE报告不足的能力.
- 评估simarep的性能与传统方法和启发式方法相比.
主要方法:
- 开发开源R包,simarep,利用患者级AE和访问数据.
- 由IntercoMPany quALity Analytics (IMPALA) 财团的三个成员公司对simarep包进行独立验证.
- 与启发式方法对比 simaerep 的检测率的比较分析.
主要成果:
- simaerep在所有三家验证公司中一致有效地确定了AE报告不足.
- 与启发式方法相比,该包显示出更高的检测率.
- 在研究持续时间的25%标志上,simaerep确定了50%的可检测部位.
结论:
- simaerep R包提供了一个强大的解决方案,用于识别临床试验中AE报告不足的情况.
- 它的整合到审计中有助于快速,整体和可重复的质量监督.
- 该工具通过及时检测AE显著提高了通过及时检测AE确保数据完整性和患者安全的能力.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
261
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
相关概念视频
Statistical Software for Data Analysis and Clinical Trials
547
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
547
Steps in Outbreak Investigation
126
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
126
Kaplan-Meier Approach
136
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
136
